Valsartan Solution
Product Images NDC 72336-910

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Valsartan (NDC 72336-910). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lifsa Drugs Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

120 mL (72336910)

120 mL (72336910)
This is a description of a medication available in two sizes - 120mL and 473mL - containing Valsartan USP, which is used to treat high blood pressure and heart failure. The usual dosage of Valsartan USP is not listed, and the pharmacist is advised to dispense the medication in a tight container. The medication should be stored at 20°C to 25°C. Other ingredients in the medication include grape flavor, methylparaben, poloxamer, potassium sorbate, propylene glycol, purified water, sodium citrate dihydrate, sodium hydroxide, and sucralose. The National Drug Code (NDC) for the medication is listed as 72336-910-79 for the 120mL size and 72336-910-89 for the 473mL size.*
FDA Label Image

Structure (Valsartan Structure)

FDA Label Image

Study (Study)

Study (Study)
This text presents data on the effects of valsartan versus captopril on mortality rates among subgroups of patients in VALIANT. The subgroups analyzed include patients of different ages, genders, ethnicities, nationalities, and beta-blocker medication use. The percentage of patients in each subgroup is listed. However, there is no information on the actual mortality rates or any detailed analysis of the results.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.